Introduction: Why China Matters — and Why Now India’s pharmaceutical sector is facing external pressures—tariff risks in key export markets, rising costs, and geopolitical friction. Meanwhile, China, with its massive population, growing healthcare spending, and increasingly open health product ecosystem, presents a compelling opportunity. Some key highlights: For Indian pharma companies, China offers a timely...
